Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Ken Suzuki(The University of Osaka), Takashi Kadowaki(Toranomon Hospital), Kiyonori Kuriki(University of Shizuoka), Masahiro Kanai(Broad Institute), Atsushi Hozawa(Tohoku University), Nakao Iwata(Fujita Health University), Shiro Ikegawa(RIKEN Center for Integrative Medical Sciences), Kenji Wakai(Japanese Society for Dialysis Therapy), Masato Akiyama(Kyushu University), Motoki Iwasaki, Toshimasa Yamauchi(The University of Tokyo), Nobuhiro Shojima(The University of Tokyo), Yoichiro Kamatani(RIKEN Center for Integrative Medical Sciences), Yukinori Okada(RIKEN Center for Integrative Medical Sciences), Yasushi Ishigaki(Iwate Medical University), Shoichiro Tsugane(International University of Health and Welfare), Taiki Yamaji, Aya Kadota(Shiga University of Medical Science), Jun Hosoe(The University of Tokyo), Kazuyoshi Ishigaki(Broad Institute), Kozo Tanno(Iwate Medical University), Norie Sawada(National Cancer Center), Koichi Matsuda(The University of Tokyo), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Yoshinori Murakami(The University of Tokyo), Masashi Ikeda(Fujita Health University), Makoto Hirata(The University of Tokyo), Makoto Sasaki(Iwate Medical University), Masayuki Yamamoto(Tohoku University), Momoko Horikoshi(RIKEN Center for Integrative Medical Sciences), Shiro Maeda(Shiga University of Medical Science), Mariko Naito(Nagoya City University)
Cited by 273
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Adiponectin and Adiponectin Receptors
|Endocrine Reviews|2005|2.6k